Sino-Singapore Syke (002912): Revenue recovery, cost reduction and efficiency helped profit exceed expectations
Sino-Singapore Syke (002912): Downstream demand gradually released, gross margin increased significantly
Sino-Singapore Syke (002912): Product structure upgrade boosts gross margin; net profit turns loss into profit
Sino-Singapore Saike (002912): Outstanding revenue growth, continuous customer and product breakthroughs
Sino-Singapore Syke (002912) 2023 Interim Report Review: Achieving Rapid Growth in Performance and Continued Investment to Improve Product Capabilities
Sino-Singapore Syke (002912): Rapid revenue growth, rich product matrix
中新赛克(002912):归母净利润预告扭亏 行业景气度提升
Sino-Singapore Syke (002912): Better demand bottomed out and reversed
Zhongxin Syke (002912) 2022 Annual Report and 2023 First Quarter Report Review: Performance was pressured by multiple factors, and the quarterly report achieved high growth
Sino-Singapore Syke (002912): Performance inflection point is about to expand data security
Sino-Singapore Syke (002912): Short-term revenue pressure awaits performance
Zhongxin Syke (002912) 2021 Annual Report and 2022 Quarterly Report Reviews: Downstream Market Investment Slows in the Short Term, Emerging Businesses Continue to Develop
Zhongxin Sike (002912): performance under short-term pressure waiting for new business transformation
Zhongxin Syke (002912) 2021 Interim Report Review: The front-end resumed positive growth and the back-end was affected by the overseas epidemic
Zhongxin Syke (002912): Short-term performance is under pressure, front-end and back-end business synergies continue to increase
Zhongxin Syke (002912): The pace of growth of back-end products can be expected to expand in the future
Zhongxin Syke (002912): Long-term traffic logic for the layout of a low level of industry sentiment
Zhongxin Secco (002912) Q1 performance Forecast Review: sustained strategic breakthroughs in product synergy lead to a steady rise in revenue
Sino-Singapore Syke (002912): Continued strong investment in R&D overseas and outstanding data analysis business
Zhongxin Sike (002912): the performance is better than expected inflection point or coming
No Data
No Data